This special supplement to The Journal of Nuclear Medicine is a detailed tabulation of
literature on FDG PET in oncology (1993–June 2000), cardiology (1986–June 2000), and …

Positron-Emission Tomography and Assessment of Cancer Therapy | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Abstract Fluorine-18 deoxyglucose (FDG) is not a very tumour-specific substance, and its
accumulation in benign lesions with increased glucose metabolism may give rise to false …

Positron emission tomography (PET) is now primarily used in oncological indication owing
to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing …

Positron emission tomography (PET) is the most powerful molecular imaging technique
currently available for clinical use. Because deranged tumour metabolism is a common …

The role of positron emission tomography (PET) during the past decade has evolved rapidly
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …

Radiation-induced lung disease (RILD) due to radiation therapy is common. Radiologic
manifestations are usually confined to the lung tissue within the radiation port and are …

BACKGROUND The role and potential value of positron emission tomography (PET)
scanning in certain tumors has been widely investigated in recent years. The authors …

We previously reported that respiratory motion is a major source of error in quantitation of
lesion activity using combined PET/CT units. CT acquisition of the lesion occurs in seconds …

Positron emission tomography (PET) has shown an increase in both sensitivity and
specificity over computed tomography (CT) in lung cancer. However, motion artifacts in the …